Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mass vaccination: when and why.

D L Heymann1, R B Aylward

  • 1World Health Organization, Geneva, Switzerland. heymannd@who.int

Current Topics in Microbiology and Immunology
|September 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful smallpox eradication: what can we learn to control COVID-19?

Journal of travel medicine·2020
Same author

A New Method for Estimating the Coverage of Mass Vaccination Campaigns Against Poliomyelitis From Surveillance Data.

American journal of epidemiology·2015
Same author

Integration, community engagement, and polio eradication in Nigeria - authors' reply.

The Lancet. Global health·2014
Same author

Eradicating polio: today's challenges and tomorrow's legacy.

Annals of tropical medicine and parasitology·2006
Same author

Protecting investments in polio eradication: the past, present and future of surveillance for acute flaccid paralysis.

Epidemiology and infection·2004
Same author

Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy.

Bulletin of the World Health Organization·2002
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Mass vaccination campaigns, historically used for smallpox, remain crucial for rapidly building herd immunity during outbreaks and introducing new vaccines. This strategy, alongside routine immunization, is vital for controlling vaccine-preventable diseases globally.

Area of Science:

  • Public Health
  • Epidemiology
  • Immunization Practices

Background:

  • Mass vaccination campaigns, historically termed 'vaccination days,' were employed in the 19th century for rapid population protection against diseases like smallpox.
  • Despite advancements in routine immunization services, such as the Expanded Programme on Immunization and GAVI support, the need for rapid, efficient population protection through mass vaccination persists.
  • Disruptions to routine immunization services, often due to population displacement or lack of prior vaccination, necessitate mass vaccination strategies.

Purpose of the Study:

  • To examine the historical and contemporary roles of mass vaccination in public health.
  • To highlight the importance of mass vaccination in achieving herd immunity during outbreaks and for new vaccine introductions.
  • To underscore the continued necessity of mass vaccination in conjunction with routine immunization for disease control.

Related Experiment Videos

Main Methods:

  • Historical analysis of vaccination campaign strategies.
  • Review of contemporary immunization program challenges and successes.
  • Examination of the principles of herd immunity and vaccine coverage.

Main Results:

  • Mass vaccination effectively increases population (herd) immunity, crucial for outbreak control and mitigating morbidity/mortality.
  • Mass vaccination accelerates disease control by rapidly increasing coverage for new vaccines during introduction into routine programs.
  • Achieving herd immunity levels through mass vaccination is essential for meeting international eradication and mortality reduction targets.

Conclusions:

  • Mass vaccination remains a critical public health tool for rapid population protection, complementing routine immunization efforts.
  • The alliance between mass vaccination and routine immunization is indispensable for achieving national and international goals in controlling vaccine-preventable diseases.
  • Effective strategies combining mass and routine immunization are vital for global health security and disease eradication in the 21st century.